Insel, Paul A.Sriram, KrishnaWiley, Shu Z.Wilderman, AndreaKatakia, TrishnaMcCann, ThaliaYokouchi, HiroshiZhang, LingzhiCorriden, RossLiu, DonglingFeigin, MichaelFrench, Randall P.Lowy, Andrew M.Murray, Fiona2018-05-222018-05-222018-05-22Insel, P A, Sriram, K, Wiley, S Z, Wilderman, A, Katakia, T, McCann, T, Yokouchi, H, Zhang, L, Corriden, R, Liu, D, Feigin, M, French, R P, Lowy, A M & Murray, F 2018, 'GPCRomics : GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targets', Frontiers in Pharmacology, vol. 9, 431. https://doi.org/10.3389/fphar.2018.004311663-9812ORCID: /0000-0002-5572-4810/work/95580095http://hdl.handle.net/2164/10478Financial support for these studies was provided by Roche, the Lymphoma and Leukemia Society, Friends of ANCHOR, an ASPET Astellas Award and grants from the National Institutes of Health, National Cancer Institute (CA189477, CA121938, CA155620). National Cancer Institute (NCI) Therapeutic Training Grant 5T32CA121938, NIH/NCI Research Grants R21 CA189477, an ASPET David Lehr Award and the Padres Pedal the Cause #PTC2017 award.111689381engSDG 3 - Good Health and Well-beingbreast cancerCancer microenvironmentchronic lymphocytic leukemiaColon CancerGPCR arrayOrphan receptorsPancreatic CancerRM Therapeutics. PharmacologyRMJournal article10.3389/fphar.2018.004319